HALSEY DRUG CO INC/NEW
3, 1998-07-10
PHARMACEUTICAL PREPARATIONS
Previous: INTEGRATED SPATIAL INFORMATION SYSTEMS INC, 8-K, 1998-07-10
Next: PACIFIC AEROSPACE & ELECTRONICS INC, 8-K, 1998-07-10



<PAGE>   1
- --------                                          
 FORM 3                                         
- --------                                          
                                                
                    U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, DC 20549

            INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

   Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
                                Section 17(a)
  of the Public Utility Holding Company Act of 1935 or Section 30(f) of the
                        Investment Company Act of 1940

<TABLE>
<S>                                        <C>                           <C>                                 <C>                 
- -----------------------------------------------------------------------------------------------------------------------------------
1. Name and Address of Reporting Person*   2. Date of Event Requiring    4. Issuer Name and Ticker or     6. If Amendment, Date 
     Shroff     Zubeen                        Statement                     Trading Symbol                    of Original
- ----------------------------------------      (Month/Day/Year)              Halsey Drug Co., Inc. (HDG)       (Month/Day/Year)
     (Last)     (First)     (Middle)             6-30-98                 ------------------------------
   610 Fifth Avenue, Rockefeller Center    ----------------------------  5. Relationship of Reporting     7. Individual or Joint/   
- ----------------------------------------   3. IRS or Social Security          Person to Issuer               Group Filing (Check
             (Street)                         Number of Reporting           (Check all applicable)           Applicable Line)       
                                              Person (Voluntary)         _X_ Director   ___  10% Owner       __ Form filed by One   
     New York,   New York     10020                                      ___ Officer    _X_   Other             Reporting Person
- --------------------------------------     ----------------------------  (give title below)  (specify below) __ Form filed by More  
      (City)      (State)      (Zip)                                                                            than One Reporting  
                                                                          General partner of Galen Partners     Person            
                                                                          III, L.P. which together with
                                                                          affiliated entities owns
                                                                          convertible debentures exercisable
                                                                          for approximately fifth percent
                                                                          (50%) of the common stock of Halsey
                                                                          Drug Co., Inc.
- -----------------------------------------------------------------------------------------------------------------------------------
                                                            TABLE 1 -- NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED      
- -----------------------------------------------------------------------------------------------------------------------------------
 1. Title of Security                         2. Amount of Securities         3. Ownership Form:         4. Nature of Indirect     
    (Instr. 4)                                   Beneficially Owned              Direct (D) or              Beneficial    
                                                 (Instr. 4)                      Indirect (I)               Ownership (Instr. 4)
                                                                                 (Instr. 5)                 
- -----------------------------------------------------------------------------------------------------------------------------------
None
- -----------------------------------------------------------------------------------------------------------------------------------

- -----------------------------------------------------------------------------------------------------------------------------------

- -----------------------------------------------------------------------------------------------------------------------------------

- -----------------------------------------------------------------------------------------------------------------------------------

- -----------------------------------------------------------------------------------------------------------------------------------

- -----------------------------------------------------------------------------------------------------------------------------------

- -----------------------------------------------------------------------------------------------------------------------------------

- -----------------------------------------------------------------------------------------------------------------------------------

- -----------------------------------------------------------------------------------------------------------------------------------
*If the form is filed by more than one Reporting Person, see Instruction 5(b)(v). 
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.                   (Over)

                                                (Print or Type Responses)                               (Bulletin No. 177, 10-15-97)
</TABLE>
                 
<PAGE>   2
 
<TABLE>
<CAPTION>
 
FORM 3 (CONTINUED)               TABLE II -- DERIVATIVE SECURITIES BENEFICIALLY OWNED
                            (E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
 
<S>                              <C>                <C>                            <C>           <C>         <C>        
- ------------------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative Security  2. Date            3. Title and Amount of         4. Conver-    5. Owner-   6. Nature of Indirect
   (Instr. 4)                       Exercisable and    Securities Underlying          sion or       ship        Beneficial Ownership
                                    Expiration Date    Derivative Security            Exercise      Form of     (Instr. 5)          
                                    (Month/Day/        (Instr. 4)                     Price of      Deriv-                         
                                    Year)                                             Deri-         ative                          
                                                                                      vative        Security:                      
                                                                                      Security      Direct                         
                                 -------------------------------------------------                  (D) or                         
                                 Date      Expira-                       Amount or                  Indirect (I)  
                                 Exercis-  tion             Title        Number                     (Instr. 5)             
                                 able      Date                          of Shares                                                 
                                                                                                                                   
- ------------------------------------------------------------------------------------------------------------------------------------
Stock Options (Right to Buy)      *         *         Common Stock       10,000           $ 2 3/8        D  
- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------
Explanation of Responses:

*Date of grant of stock option June 30, 1998; Date Exercisable and Expiration Date to be determined.

                                                                                   /s/ Zubeen Shroff                   July 9, 1998
**Intentional misstatements or omissions of facts constitute Federal Criminal      -------------------------------     ------------
  Violations.                                                                      **Signature of Reporting Person        Date
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).                               

Note. File three copies of this Form, one of which must be manually signed.                                        Page 2     
  If space provided is insufficient, See Instruction 6 for procedure.                                   (Bulletin No. 177, 10-15-97)

                                                                                                                                 
</TABLE>
 


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission